Our

Company

BMEYE is a technology-based, market driven company which was established in April 2005, bringing over 30 years of research and development experience to our customers, focused on finger arterial pressure and cardiac output technologies. Our technologies have been validated extensively and are used in groundbreaking products for the space agencies and experimental market launches. Our products are considered as thoroughly evaluated, and have been documented in over 800 publications.

Achieving miniaturization and increased user-accessibility, required for broad adoption, were the most important challenges BMEYE faced when developing the next generation product: Nexfin.

Building on the experience we are convinced that, with the introduction of Nexfin, we offer cardiovascular monitors that will be used in every hospital and for many indications. We will continue to improve our products in close cooperation with physicians, through research, development and clinical evaluations.

The Nexfin, BMEYE’s first product, obtained CE and FDA clearance in 2007, is a unique non invasive blood pressure and cardiac output monitor, offering a precise hemodynamic profile with real-time data posted within a minute.

Global

Business

BMEYE is a Dutch company based in Amsterdam, The Netherlands. We have a close cooperation in joint research projects with many medical centers and universities all over the globe. Our technology is used in the practice of many clinicians and researchers worldwide, in several application areas.

With the launch of Nexfin we are building a network of strong distributors, to open new horizons, to make it possible that physicians will be able to use our equipment to diagnose their patients.